Arkolith/Insider Trading/DTIL/Form 4

Amoroso Michael

President and CEO, DirectorPRECISION BIOSCIENCES INC (DTIL) · full profile →Form 4 · filed Nov 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 3, 2025Sell(S)3K$6.49$22K116K
Nov 2, 2025Option exercise(M)9K—$0119K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 3, 2025Option exercise(M)9K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-048855) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML